🔎 Trials Near Me

Acasă › Cancer pulmonar › New York

Studii clinice pentru Cancer pulmonar în New York

93 studii pentru Cancer pulmonar caută participanți în New York.

Orașe în New York

Text oficial al studiului (în engleză)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Northwell Health Imbert Cancer Center, Bay Shore
  • Maimonides Medical Center, Brooklyn
  • Roswell Park Cancer Institute, Buffalo
  • și încă 18
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 2 oct. 2026 · NCT04267848

Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery

  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • și încă 1
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 2 oct. 2026 · NCT04991025

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering, New York
În curs de recrutareFaza 1/2
Vârste de 12 ani și peste · Toate sexele · Actualizat 2 oct. 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Queens Hospital Center, Jamaica
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Stony Brook University Medical Center, Stony Brook
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de la 40 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Roswell Park Cancer Institute IDS, Buffalo
  • Memorial Sloan Kettering Hospital, New York
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT06172478

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • Glens Falls Hospital, Glens Falls
  • Upstate Cancer Center at Oswego, Oswego
  • University of Rochester, Rochester
  • și încă 7
În curs de recrutareFaza 3
Vârste de 70 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Commack, Commack
  • The Cancer Institute at Saint Francis Hospital, East Hills
  • și încă 13
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT04181060

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT06625775

Empathic Communication Skills (ECS) Training

  • Roswell Park Cancer Institute (Data Collection Only), Buffalo
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
În curs de recrutareVoluntari sănătoși bineveniți
Vârste de la 18 la 100 · Toate sexele · Actualizat 1 oct. 2026 · NCT05456841

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Montefiore Medical Center-Einstein Campus, The Bronx
  • Montefiore Medical Center-Weiler Hospital, The Bronx
  • Montefiore Medical Center - Moses Campus, The Bronx
  • și încă 1
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT06498635

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • NYU Langone's Perlmutter Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • Optum Medical Care, PC, Westbury
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 30 sept. 2026 · NCT06765109

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 29 sept. 2026 · NCT06881784

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

  • MSK Commack, Commack
  • MSK Westchester, East White Plains
  • Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City
  • și încă 3
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07476287

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

  • GSK Investigational Site, East Syracuse
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07099898

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • Cayuga Medical Center ( Site 0086), Ithaca
  • University Hospital at Stony Brook ( Site 0054), Stony Brook
  • White Plains Hospital ( Site 0091), White Plains
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • New York Oncology Hematology, Albany
  • New York Oncology Hematology, Clifton Park
  • Hematology Oncology Associates of Rockland, Nyack
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Hematology Oncology Associates of Rockland, Nyack
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 sept. 2026 · NCT06758401

A Registry for People With Lung Cancer

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • și încă 1
În curs de recrutareStudiu observațional
Vârste de 18 ani și peste · Toate sexele · Actualizat 24 sept. 2026 · NCT06424327

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

  • WMCHealth Advanced Physician Services, Hawthorne
  • Local Institution - 0128, Rochester
  • Local Institution - 0518, Schenectady
În curs de recrutareFaza 2/3
Vârste de 18 ani și peste · Toate sexele · Actualizat 23 sept. 2026 · NCT07063745

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

  • Research Site, Buffalo
În curs de recrutareFaza 2
Vârste de la 18 la 95 · Toate sexele · Actualizat 23 sept. 2026 · NCT05061550

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • Nuvance Health, Poughkeepsie
  • Suny-Stony Brook University Cancer Center, Stony Brook
  • White Plains Hospital, White Plains
În curs de recrutareFaza 2/3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06712316

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1/2
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06128551

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
  • NYU Langone Health, New York
  • Weill Cornell Medical College, New York
  • și încă 1
În curs de recrutareFaza 2/3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07100080

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

  • NYU Langone Health Perlmutter Cancer Center, New York
În curs de recrutareFaza 1/2
Vârste de 18 ani și peste · Toate sexele · Actualizat 21 sept. 2026 · NCT07629960

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 17 sept. 2026 · NCT07349537

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1/2
Vârste de 18 ani și peste · Toate sexele · Actualizat 17 sept. 2026 · NCT06287775

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1/2
Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT05786924

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 10 sept. 2026 · NCT06293898

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  • SUNY Upstate Medical University, Syracuse
  • Montefiore Einstein Cancer Center, The Bronx
  • Clinical Research Alliance, Westbury
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 8 sept. 2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Maimonides Cancer Center, Brooklyn
  • Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
  • și încă 3
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 8 sept. 2026 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 8 sept. 2026 · NCT06561685

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • NYU Langone Health - Long Island, Mineola
  • New York University (NYU) Clinical Cancer Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 4 sept. 2026 · NCT06400472

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

  • Avenzo Therapeutics Recruiting Site, New York
În curs de recrutareFaza 1/2
Vârste de la 18 la 75 · Toate sexele · Actualizat 4 sept. 2026 · NCT07038343

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

  • Roswell Park Cancer Institute, Buffalo
  • Perlmutter Cancer Center - NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 3 sept. 2026 · NCT06343402

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

  • Northwell Health/R.J. Zuckerberg Cancer Center, Lake Success
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 1 sept. 2026 · NCT07185997

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • Cornell University - NewYork-Presbyterian/Weill Cornell Medical Center, New York
  • White Plains Hospital, White Plains
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 1 sept. 2026 · NCT06712355

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • New York Cancer & Blood Specialists, New York
  • University of Rochester - Wilmot Cancer Institute, Rochester
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 27 aug. 2026 · NCT06582017

Hotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative Radiotherapy for the Treatment of Early-Stage Non-Small Cell Lung Cancer

  • Roswell Park Cancer Institute, Buffalo
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 26 aug. 2026 · NCT07718672

Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer

  • Roswell Park Cancer Institute, Buffalo
În curs de recrutare
Vârste de 21 ani și peste · Toate sexele · Actualizat 19 aug. 2026 · NCT05787834

GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer

  • Roswell Park Cancer Institute, Buffalo
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 19 aug. 2026 · NCT07017829

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.